Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy
Pharmacotherapy
.
2023 Apr;43(4):351-353.
doi: 10.1002/phar.2788.
Epub 2023 Mar 26.
Authors
Xiaolan Mo
1
2
,
Xiujuan Chen
3
,
Huasong Zeng
4
,
Wei Zheng
1
,
Chifong Ieong
2
,
Huixian Li
3
,
Qiongbo Huang
1
,
Zichuan Xu
4
,
Jinlian Yang
1
,
Qianying Liang
1
,
Huiying Liang
3
,
Xia Gao
4
,
Min Huang
2
,
Jiali Li
2
Affiliations
1
Department of Pharmacy, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
2
Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
3
Department of Medical Big Data Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
4
Division of Nephrology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
PMID:
36967107
DOI:
10.1002/phar.2788
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Humans
Immunosuppressive Agents / therapeutic use
Machine Learning
Nephrotic Syndrome* / drug therapy
Tacrolimus* / therapeutic use
Substances
Tacrolimus
Immunosuppressive Agents
Biomarkers